Literature DB >> 16652385

A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.

Maite Hernandez1, Qing Shao, Xiang-Jiao Yang, Shi-Ping Luh, Mustapha Kandouz, Gerald Batist, Dale W Laird, Moulay A Alaoui-Jamali.   

Abstract

BACKGROUND: The connexin 43 gene (cx43, GJA1) mediates gap junctional intercellular communication (GJIC), which regulates tissue homeostasis. cx43 is frequently downregulated in prostate cancer. We investigated the role of a histone deacetylase (HDAC)-dependent mechanism in the transcriptional repression of cx43 in a panel of prostate cancer cells.
METHODS: The impact of Trichostatin A (TSA), an inhibitor of HDAC, on exogenous and endogenous cx43 gene transcription was examined by the luciferase assay, Northern blot, nuclear run-on, Western blot, and chromatin immunoprecipitation assays.
RESULTS: Trichostatin A induces transcription of cx43 gene and GJIC. The co-activator p300/CBP synergizes with TSA for cx43 promoter activation. We identified a promoter region where cooperation between Ap1 and Sp1 elements was essential for TSA-induced cx43 transcription. TSA increased the level of hyperacetylated histones bound to cx43 promoter.
CONCLUSION: Our results highlight the potential utility of inhibitors of HDAC to restore cx43 gene expression in prostate cancer. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652385     DOI: 10.1002/pros.20451

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  14 in total

Review 1.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

2.  Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters.

Authors:  Qi-Lian Liang; Bi-Rong Wang; Guo-Qiang Chen; Guo-Hong Li; Yan-Yun Xu
Journal:  Med Oncol       Date:  2009-11-12       Impact factor: 3.064

Review 3.  The role of histone deacetylases in prostate cancer.

Authors:  Ata Abbas; Sanjay Gupta
Journal:  Epigenetics       Date:  2008-11-24       Impact factor: 4.528

4.  Androgen signaling disruption during fetal and postnatal development affects androgen receptor and connexin 43 expression and distribution in adult boar prostate.

Authors:  Anna Hejmej; Ewelina Górowska; Małgorzata Kotula-Balak; Katarzyna Chojnacka; Marta Zarzycka; Justyna Zając; Barbara Bilińska
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

Review 5.  Connexins: Synthesis, Post-Translational Modifications, and Trafficking in Health and Disease.

Authors:  Trond Aasen; Scott Johnstone; Laia Vidal-Brime; K Sabrina Lynn; Michael Koval
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

Review 6.  Regulation of connexin signaling by the epigenetic machinery.

Authors:  Mathieu Vinken
Journal:  Biochim Biophys Acta       Date:  2015-11-10

7.  Histone deacetylase inhibition reduces cardiac connexin43 expression and gap junction communication.

Authors:  Qin Xu; Xianming Lin; Laura Andrews; Dakshesh Patel; Paul D Lampe; Richard D Veenstra
Journal:  Front Pharmacol       Date:  2013-04-15       Impact factor: 5.810

8.  Specific deletion of AMP-activated protein kinase (α1AMPK) in murine oocytes alters junctional protein expression and mitochondrial physiology.

Authors:  Michael J Bertoldo; Edith Guibert; Melanie Faure; Christelle Ramé; Marc Foretz; Benoit Viollet; Joëlle Dupont; Pascal Froment
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

Review 9.  AMPK: a master energy regulator for gonadal function.

Authors:  Michael J Bertoldo; Melanie Faure; Joëlle Dupont; Pascal Froment
Journal:  Front Neurosci       Date:  2015-07-14       Impact factor: 4.677

10.  Possible role of hemichannels in cancer.

Authors:  Kurt A Schalper; Daniel Carvajal-Hausdorf; Mauricio P Oyarzo
Journal:  Front Physiol       Date:  2014-06-27       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.